These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 28620050)
1. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors. Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050 [TBL] [Abstract][Full Text] [Related]
2. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions. Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616 [TBL] [Abstract][Full Text] [Related]
3. Restricted processing of CD16a/Fc γ receptor IIIa Patel KR; Roberts JT; Subedi GP; Barb AW J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305 [TBL] [Abstract][Full Text] [Related]
4. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells. Hills AE; Patel A; Boyd P; James DC Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148 [TBL] [Abstract][Full Text] [Related]
6. Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus. Blundell PA; Lu D; Wilkinson M; Dell A; Haslam S; Pleass RJ J Immunol; 2019 Mar; 202(5):1595-1611. PubMed ID: 30683699 [TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic Fc glycosylation via engineered aldehyde tags. Smith EL; Giddens JP; Iavarone AT; Godula K; Wang LX; Bertozzi CR Bioconjug Chem; 2014 Apr; 25(4):788-95. PubMed ID: 24702330 [TBL] [Abstract][Full Text] [Related]
8. Impact of Fc N-glycan sialylation on IgG structure. Zhang Z; Shah B; Richardson J MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531 [TBL] [Abstract][Full Text] [Related]
9. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070 [TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry investigation of glycosylation on the NXS/T sites in recombinant glycoproteins. Sokolowska I; Ngounou Wetie AG; Roy U; Woods AG; Darie CC Biochim Biophys Acta; 2013 Aug; 1834(8):1474-83. PubMed ID: 23632316 [TBL] [Abstract][Full Text] [Related]
11. Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile. Lee JH; Jeong YR; Kim YG; Lee GM Biotechnol Bioeng; 2017 Aug; 114(8):1721-1732. PubMed ID: 28266015 [TBL] [Abstract][Full Text] [Related]
12. The Structural Role of Antibody N-Glycosylation in Receptor Interactions. Subedi GP; Barb AW Structure; 2015 Sep; 23(9):1573-1583. PubMed ID: 26211613 [TBL] [Abstract][Full Text] [Related]
13. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors. Blundell P; Pleass R Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483 [TBL] [Abstract][Full Text] [Related]
14. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G1 Fc domain motions: implications for Fc engineering. Frank M; Walker RC; Lanzilotta WN; Prestegard JH; Barb AW J Mol Biol; 2014 Apr; 426(8):1799-811. PubMed ID: 24522230 [TBL] [Abstract][Full Text] [Related]
16. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms. Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585 [TBL] [Abstract][Full Text] [Related]
17. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products. Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J; Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438 [TBL] [Abstract][Full Text] [Related]
18. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. Mimura Y; Kelly RM; Unwin L; Albrecht S; Jefferis R; Goodall M; Mizukami Y; Mimura-Kimura Y; Matsumoto T; Ueoka H; Rudd PM J Immunol Methods; 2016 Jan; 428():30-6. PubMed ID: 26627984 [TBL] [Abstract][Full Text] [Related]
19. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289 [TBL] [Abstract][Full Text] [Related]
20. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]